Prospective Evaluation of 18f-NaF and 18f-FDG PET/CT in Detection of Occult Metastatic Disease in Biochemical Recurrence of Prostate Cancer
Clinical Nuclear Medicine - United States
doi 10.1097/rlu.0b013e318252d829
Full Text
Open PDFAbstract
Available in full text
Date
July 1, 2012
Authors
Publisher
Ovid Technologies (Wolters Kluwer Health)